IMGN901 in Combination With Lenalidomide and Dexamethasone
NCT00991562
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
IMGN901
Sponsor
ImmunoGen, Inc.